ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of a Novel Topical Therapy for Tinea Pedis (Athlete's Foot)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00848666
Recruitment Status : Unknown
Verified February 2009 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : February 20, 2009
Last Update Posted : February 24, 2009
Sponsor:
Information provided by:
Hillel Yaffe Medical Center

Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of a novel topical therapy in patients with laboratory confirmed tinea pedis. During the follow-up period clinical and mycological examinations will be performed.

Condition or disease Intervention/treatment Phase
Tinea Pedis Drug: Topical therapy Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : April 2009
Estimated Primary Completion Date : April 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: I
Patients with tinea pedis
Drug: Topical therapy
One time immersion of the feet in a liquid containing water, alcohol, vinegar, benzoic acid and salicylic acid for a total of 30 minutes.



Primary Outcome Measures :
  1. Cure of tinea pedis [ Time Frame: One year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Otherwise healthy patients with laboratory proven tinea pedis

Exclusion Criteria:

  • Age lower than 18 and higher than 80

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00848666


Locations
Israel
Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Contact: Kahana    972-4-6304667    kahanam@hy.health.gov.il   
Principal Investigator: Michael Kahana, MD         
Sponsors and Collaborators
Hillel Yaffe Medical Center

Responsible Party: Dr. Michael Kahana, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT00848666     History of Changes
Other Study ID Numbers: HYMC 48-08
First Posted: February 20, 2009    Key Record Dates
Last Update Posted: February 24, 2009
Last Verified: February 2009

Additional relevant MeSH terms:
Tinea
Tinea Pedis
Dermatomycoses
Skin Diseases, Infectious
Infection
Mycoses
Skin Diseases
Foot Dermatoses
Foot Diseases
Pruritus
Skin Manifestations
Signs and Symptoms